Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-12

FDA Approved: OLANZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

This FDA document relates to a supplemental application for the generic antipsychotic olanzapine from Aurobindo Pharma Limited. The action pertains to regulator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)